BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $309,696 | +68.5% | 8,206 | +103.5% | 0.01% | -18.2% |
Q2 2023 | $183,744 | -1.7% | 4,033 | -12.5% | 0.01% | -21.4% |
Q1 2023 | $186,991 | -23.2% | 4,610 | -3.5% | 0.01% | -26.3% |
Q4 2022 | $243,522 | -7.8% | 4,778 | -2.7% | 0.02% | -20.8% |
Q3 2022 | $264,000 | -13.2% | 4,910 | +3.6% | 0.02% | 0.0% |
Q2 2022 | $304,000 | -16.9% | 4,738 | +0.5% | 0.02% | -4.0% |
Q1 2022 | $366,000 | -16.1% | 4,716 | -7.2% | 0.02% | -16.7% |
Q4 2021 | $436,000 | +6.1% | 5,083 | -0.6% | 0.03% | -3.2% |
Q3 2021 | $411,000 | -6.4% | 5,114 | -6.2% | 0.03% | -8.8% |
Q2 2021 | $439,000 | +0.7% | 5,454 | +5.4% | 0.03% | -5.6% |
Q1 2021 | $436,000 | +1.9% | 5,174 | -3.1% | 0.04% | -7.7% |
Q4 2020 | $428,000 | -0.9% | 5,339 | -0.5% | 0.04% | -15.2% |
Q3 2020 | $432,000 | -4.4% | 5,368 | +2.2% | 0.05% | -11.5% |
Q2 2020 | $452,000 | +27.0% | 5,255 | +19.9% | 0.05% | 0.0% |
Q1 2020 | $356,000 | -3.0% | 4,384 | 0.0% | 0.05% | +15.6% |
Q4 2019 | $367,000 | -4.2% | 4,384 | 0.0% | 0.04% | -11.8% |
Q3 2019 | $383,000 | +6.7% | 4,384 | 0.0% | 0.05% | +6.2% |
Q2 2019 | $359,000 | -3.5% | 4,384 | -4.3% | 0.05% | -5.9% |
Q1 2019 | $372,000 | +43.6% | 4,579 | +16.6% | 0.05% | +27.5% |
Q4 2018 | $259,000 | +21.6% | 3,928 | +41.9% | 0.04% | +37.9% |
Q3 2018 | $213,000 | -86.4% | 2,768 | -88.6% | 0.03% | -86.3% |
Q4 2017 | $1,566,000 | +3.0% | 24,230 | 0.0% | 0.21% | +7.1% |
Q3 2017 | $1,520,000 | +3.6% | 24,230 | -0.0% | 0.20% | -7.5% |
Q2 2017 | $1,467,000 | +46.4% | 24,239 | +25.5% | 0.21% | +46.6% |
Q1 2017 | $1,002,000 | +12.5% | 19,318 | -3.9% | 0.15% | +1.4% |
Q4 2016 | $891,000 | – | 20,104 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |